Calico is an Alphabet-founded research and development company whose mission is to harness advanced technologies and model systems to increase our understanding of the biology that controls human aging. We will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Calico’s highly innovative technology labs, its commitment to curiosity-driven discovery science and, with academic and industry partners, its vibrant drug-development pipeline together create an inspiring and exciting place to catalyze and enable medical breakthroughs. Calico is currently seeking exceptional candidates who share our passion for understanding the science of aging and developing therapeutics to address age-related diseases.
Enable Injections
Unlock to Claim this listing
Add / Modify Company
0.60
Overall Excellence Rating
Industry
Pharmaceuticals & BiotechnologyCategory
Medical Equipment ManufacturingESG/Ethical Impact
Inovative Drug Delivery: Enable Injections’ focus on wearable devices for drug delivery could lead to more efficient and targeted drug administration, potentially reducing waste associated with traditional methods. Material Selection: The company prioritize eco-friendly and sustainable materials in its device manufacturing to minimize environmental impact. Collaboration: Enable Injections collaborate with partners and suppliers to promote sustainable practices within the medical device industry. Enable Injections’ wearable devices aim to improve patient comfort and compliance, enhancing overall treatment experiences. Healthcare Access: The company’s technology provide more accessible and user-friendly options for patients requiring frequent drug administration. Enable Injections’ governance structure likely includes a leadership team responsible for strategic decisions and ethical practices. Ethical Device Development: The company uphold high ethical standards in the design, development, and testing of its drug delivery devices, ensuring patient safety and regulatory compliance. Enable Injections prioritize transparent communication with stakeholders about its technology, regulatory approvals, and ethical considerations. Enable Injections’ ESG efforts contribute to its long-term financial success by enhancing its reputation, attracting responsible investors, and improving operational efficiency. Innovation: The company’s wearable drug delivery devices lead to breakthroughs in patient-centered healthcare solutions, increasing market value and growth potential. Investor Confidence: Strong ESG performance attract investors who prioritize companies with responsible and ethical business practices. Enable Injections’ commitment to patient safety ensures that its wearable devices adhere to rigorous ethical and safety standards. Data Security: The company’s operations prioritize data security and privacy, especially given the potential connectivity of wearable medical devices.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us

Awards Received
2023
Revenues
14800000.00
Website Traffic
Employee Rating
3.70
Customer Rating
3.40
Company Size
100-1000
ESG Risk Rating
3.00